Aortic valve replacement in intermediate risk patients in the international community: Time to hop on the TAVI train

Transcatheter aortic valve implantation (TAVI) has emerged as a disruptive treatment modality for severe aortic stenosis. Several factors led to the success of TAVI including ease of its use, tolerance of the patients to the procedure, rapidity of recovery and robustness of the data proving its efficacy and safety. As a result, TAVI has become the treatment of choice in high risk and inoperable patients, which led to its rapid adoption in these...